These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3919448)

  • 1. Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
    Thomas MG; Giles TD
    South Med J; 1985 Feb; 78(2):205-6. PubMed ID: 3919448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes as a manifestation of mexiletine toxicity.
    Cocco G; Strozzi C; Chu D; Pansini R
    Am Heart J; 1980 Dec; 100(6 Pt 1):878-80. PubMed ID: 7446392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine therapy for ventricular tachycardia.
    Maddox RW; Arnold WS
    South Med J; 1985 Apr; 78(4):482-3. PubMed ID: 3983671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
    Roden DM; Woosley RL; Primm RK
    Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans.
    Duff HJ; Mitchell LB; Manyari D; Wyse DG
    J Am Coll Cardiol; 1987 Nov; 10(5):1149-56. PubMed ID: 3668109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine for treatment of torsade de pointes.
    Shah A; Schwartz H
    Am Heart J; 1984 Mar; 107(3):589-91. PubMed ID: 6695705
    [No Abstract]   [Full Text] [Related]  

  • 11. A canine model of torsades de pointes.
    Leichter D; Danilo P; Boyden P; Rosen TS; Rosen MR
    Pacing Clin Electrophysiol; 1988 Dec; 11(12):2235-45. PubMed ID: 2463611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trials.
    Frank MJ; Watkins LO; Prisant LM; Smith MS; Russell SL; Abdulla AM; Manwaring RL
    J Clin Pharmacol; 1991 Mar; 31(3):222-8. PubMed ID: 2019663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine in the treatment of recurrent ventricular tachycardia. Prediction of long-term arrhythmia suppression from acute and short-term response.
    Wang RY; Lee PK; Wong KL; Chow MS
    J Clin Pharmacol; 1983; 23(2-3):89-92. PubMed ID: 6853747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine in lidocaine-resistant ventricular tachycardia.
    Abinader EG
    Am Heart J; 1984 Apr; 107(4):808-9. PubMed ID: 6702581
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prolonged QT interval and "torsades de pointes" after therapy with prenylamin (Segontin) (author's transl)].
    Burri C; Ajdacic K; Michot F
    Schweiz Rundsch Med Prax; 1981 Apr; 70(16):717-20. PubMed ID: 7335622
    [No Abstract]   [Full Text] [Related]  

  • 20. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.